Ed Arce's Stock Ratings

HC Wainwright & Co. Analyst

Ed Arce is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

12.1%

Smart Score

65.9%

Overall Average Return Percentile

65th

Number of Ratings

308
Buy NowGet Alert
05/17/2024ETNBBuy Now
89bio
$8.90225.84% → $29ReiteratesBuy → BuyGet Alert
05/16/2024ETNBBuy Now
89bio
$8.90225.84% → $29ReiteratesBuy → BuyGet Alert
05/16/2024ACXPBuy Now
Acurx Pharmaceuticals
$2.19447.95%$12 → $12ReiteratesBuy → BuyGet Alert
05/16/2024SGMTBuy Now
Sagimet Biosciences
$4.67585.96% → $32ReiteratesBuy → BuyGet Alert
05/15/2024PLRXBuy Now
Pliant Therapeutics
$15.50132.26% → $36ReiteratesBuy → BuyGet Alert
05/15/2024DRRXBuy Now
Durect
$0.90——Reiterates → NeutralGet Alert
05/15/2024TLPHBuy Now
Talphera
$1.12435.19% → $6ReiteratesBuy → BuyGet Alert
05/15/2024GNFTBuy Now
Genfit
$3.79190.24% → $11ReiteratesBuy → BuyGet Alert
05/14/2024UNCYBuy Now
Unicycive Therapeutics
$1.04332.73% → $4.5ReiteratesBuy → BuyGet Alert
05/14/2024ITRMBuy Now
Iterum Therapeutics
$1.48305.41% → $6ReiteratesBuy → BuyGet Alert
05/14/2024TERNBuy Now
Terns Pharma
$5.92-7.09% → $5.5ReiteratesNeutral → NeutralGet Alert
05/13/2024AKROBuy Now
Akero Therapeutics
$20.36145.58% → $50ReiteratesBuy → BuyGet Alert
05/10/2024ETNBBuy Now
89bio
$8.90225.84%$31 → $29MaintainsBuyGet Alert
05/09/2024MIRMBuy Now
Mirum Pharmaceuticals
$24.75134.34% → $58ReiteratesBuy → BuyGet Alert
05/08/2024MDGLBuy Now
Madrigal Pharmaceuticals
$215.4181.05%$425 → $390MaintainsBuyGet Alert
05/07/2024TVTXBuy Now
Travere Therapeutics
$6.69184.01% → $19ReiteratesBuy → BuyGet Alert
05/07/2024ENTABuy Now
Enanta Pharma
$13.06106.74%$28 → $27MaintainsBuyGet Alert
05/07/2024PLRXBuy Now
Pliant Therapeutics
$15.50132.26% → $36ReiteratesBuy → BuyGet Alert
05/02/2024SGMTBuy Now
Sagimet Biosciences
$4.67585.96% → $32Initiates → BuyGet Alert
04/30/2024TERNBuy Now
Terns Pharma
$5.92-7.09% → $5.5ReiteratesNeutral → NeutralGet Alert
04/30/2024ITRMBuy Now
Iterum Therapeutics
$1.48305.41% → $6ReiteratesBuy → BuyGet Alert
04/24/2024TVTXBuy Now
Travere Therapeutics
$6.69184.01%$17 → $19MaintainsBuyGet Alert
04/09/2024GALTBuy Now
Galectin Therapeutics
$3.17247% → $11ReiteratesBuy → BuyGet Alert
04/08/2024CDTXBuy Now
Cidara Therapeutics
$11.28-46.81%$120 → $120MaintainsBuyGet Alert
04/05/2024GNFTBuy Now
Genfit
$3.79190.24% → $11ReiteratesBuy → BuyGet Alert
04/02/2024MIRMBuy Now
Mirum Pharmaceuticals
$24.75134.34%$58 → $58MaintainsBuyGet Alert
04/01/2024GALTBuy Now
Galectin Therapeutics
$3.17247% → $11ReiteratesBuy → BuyGet Alert
04/01/2024ITRMBuy Now
Iterum Therapeutics
$1.48305.41% → $6ReiteratesBuy → BuyGet Alert
04/01/2024IVABuy Now
Inventiva
$3.80478.95% → $22ReiteratesBuy → BuyGet Alert
04/01/2024ASMBBuy Now
Assembly Biosciences
$14.43——Reiterates → NeutralGet Alert

Recent Analyst Stock Rating News

Analyst Ratings For Mirum Pharmaceuticals
Expert Outlook: Travere Therapeutics Through The Eyes Of 6 Analysts
These Analysts Revise Their Forecasts On Pliant Therapeutics Following Q1 Earnings
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know
Analyst Ratings For Mirum Pharmaceuticals
Cracking The Code: Understanding Analyst Reviews For Mirum Pharmaceuticals
Peeling Back The Layers: Exploring Travere Therapeutics Through Analyst Insights
The Analyst Verdict: Arcturus Therapeutics In The Eyes Of 4 Experts
Critical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free